Secondary Schizophrenia (16 page)

34. Svendsen M. Children’s imaginary

experience: a final summary and

involvement in the mechanism of

companions. Arch Neurol

discussion. Brain, 1963.
86
:
action of hallucinogenic agents.

Psychiatry, 1934.
12
:985–9.

595–96.

Life Sci, 1984.
35
:2505–11.

35. Schaeffer C. Imaginary

47. West C. (1962). Hallucinations.

58. Abraham H., Aldridge A., Gogia

companions and creative

New York: Grune & Stratton.

P. The psychopharmacology of

adolescents. Dev Psychol, 1969.

48. Cogan D. Visual hallucinations as

hallucinogens.

1
:747–9.

release phenomena. Graefes Arch

Psychopharmacology, 1996.

36. Bonne O.,
et al.
Childhood

Clin Exp Opthal, 1973.
188
:
14
:285–98.

imaginary companionship and

139–50.

59. Goetz C.,
et al.
Early

mental health in adolescence.

49. Manford M., Andermann F.

dopaminergic drug-induced

Child Psychiatry Hum Dev, 1999.

Complex visual hallucinations:

hallucinations in Parkinsonian

29
:277–86.

clinical and neurobiological

patients. Neurology, 1998.

37. Simonds J. Hallucinations in

insights. Brain, 1998.
121
:
51
:811–14.

nonpsychotic children and

1819–40.

60. Angrist B.,
et al.
Amphetamine

adolescents. J Youth Adolesc, 1975.

50. ffytche D., Howard R. The

psychosis: behavioural and

4
:171–82.

perceptual consequences of visual

biochemical aspects. J Psychiatr

38. Balk D. Adolescents’ grief

loss: ‘positive’ pathologies of

Res., 1974.
11
:13–23.

reactions and self-concept

vision. Brain, 1999.
122
:
61. Dubois B.,
et al.
Cholinergic

perceptions following sibling

1247–60.

dependent cognitive deficits in

death: a study of 33 teenagers.

51. ffytche D.,
et al.
The anatomy

Parkinson’s disease. Ann Neurol.,

J Youth Adolesc, 1983.
12
:
of conscious vision: an fMRI

1987.
22
:26–30.

137–61.

study of visual hallucinations.

62. Perry E.,
et al.
Evidence of a

39. Adair D., Keshavan M. The

Nature Neurosci, 1998.
1
:738–
monoaminergic–cholinergic

Charles Bonnet Syndrome and

42.

imbalance related to visual

grief reaction. Am J Psychiatry,

52. Howard R.,
et al.
Seeing visual

hallucinations in Lewy body

1988.
145
:895.

hallucinations with functional

dementia. J Neurochem., 1991.

40. Olson P., Suddeth J., Peterson P.

magnetic resonance imaging.

55
:1454–6.

Hallucinations of widowhood.

Dement Geriatr Cogn Disord,

63. McKeith I.,
et al.
Efficacy of

J Am Geriatr Soc, 1985.
33
:
1997.
8
:73–77.

rivastigmine in dementia with

543–7.

53. Lepore F. Spontaneous visual

Lewy bodies: a randomised,

41. Grimby A. Bereavement among

phenomena with visual loss: 104

double-blind, placebo-controlled

elderly people: grief reactions,

patients with lesions of retinal and

international study. Lancet, 2000.

post-bereavement hallucinations

neural afferent pathways.

356
:2031–6.

and quality of life. Acta Psychiatr

Neurology, 1990.
40
:
64. Packard R. Delirium. Neurologist,

Scand, 1993.
87
:72–80.

444–7.

2001.
7
:327–40.

42. Mullaney D.,
et al.
Effects of

54. Galasko D., Kwo-On-Yuen P., Thal

65. Brown T. (2000). Basic

sustained continuous

L. Intracranial mass lesions

mechanisms in the pathogenesis

performance on subjects working

associated with late-onset

of delirium. In Psychiatric care of

alone and in pairs. Percept Mot

psychosis and depression.

the medical patient, Stoudemire

Skills, 1983.
57
:819–32.

Psychiatr Clin North Am, 1988.

A., Fogel B., Greenberg D. (Eds.).

43. Mullaney D.,
et al.
Sleep loss and
11
:151–66.

New York: Oxford University

nap effects on sustained

55. Perry E., Perry R. Acetylcholine

Press, pp. 571–80.

continuous performance.

and hallucinations:

Psychophysiology, 1983.

66. Nevo I., Hamon M.

disease-related compared to

20
:643–51.

Neurotransmitter and

drug-induced alterations in

neuromodulatory mechanisms

44. Forrer G. Benign auditory and

human consciousness. Brain

involved in alcohol abuse and

visual hallucinations. Arch Gen

Cogn, 1995.
28
:240–58.

alcoholism. Neurochem Int., 1995.

Psychiatry, 1964.
3
:95–8.

56. Perry E.,
et al.
Convergent

26
:305–36.

45. Walsh F., Hoyt W. (1969). Clinical

cholinergic activities in aging and

67. Collerton D., Perry E., McKeith I.

neuro-ophthalmology. 3rd ed.

Alzheimer’s disease. Neurobiol

Why people see things that are

Baltimore: Williams & Wilkins.

Aging, 1992.
13
:393–400.

not there: a novel perception and

46. Penfield W., Perot P. The brain’s

57. Glennon R., Titeler M.,

attention deficit model for

McKenney J. Evidence for 5HT2

recurrent complex visual

Introduction – Section 1

hallucinations. Behav Brain Sci.,

delirium? Focus on acetylcholine

Alzheimer’s disease: review of the

2005.
28
:737–94.

and dopamine. Semin Clin

brain decade. Psychosomatics,

68. Ndetei D., Singh A.

Neuropsychiatry, 2000.
5
:
2003.
44
:388–401.

Hallucinations in Kenyan

132–48.

89. Lin S., Yu C., Pai M. The occipital

schizophrenic patients. Acta

79. Flacker J., Lipsitz L. Neural

white matter lesions in

Psychiatr Scand., 1983.
67
:144–7.

mechanisms of delirium: current

Alzheimer’s disease patients with

69. Roberts J. (1984). Differential

hypotheses and evolving concepts.

visual hallucinations. Clin

diagnosis in neuropsychiatry. New

J Gerontol, 1999.
54
:8239–46.

Imaging, 2006.
30
:388–93.

York: John Wiley & Sons.

80. Cowen M., Lawrence A. The role

90. Lewis D.,
et al.
Laminar and

70. David A. Auditory hallucinations:

of opioid–dopamine interactions

regional distributions of

phenomenology,

in the induction and maintenance

neurofibrillary tangles and

neuropsychology and

of ethanol consumption. Prog

neuritic plaques in Alzheimer’s

neuroimaging update. Acta

Neuropharmacol Biol Psychiatry,

disease: a quantitative study of

Psychiatr Scand Suppl, 1999.

1999.
23
:1171–212.

visual and auditory cortices. J

395
:95–104.

81. Piazza P., Le Moal M.

Neurosci, 1987.
7
:1799–1808.

71. Posner M.,
et al.
Asymmetries in

Glucocorticoids as a substrate of

91. Foerster O. The cerebral cortex in

hemispheric control of attention

reward: physiological and

man. Lancet, 1931.
2
:309–19.

in schizophrenia. Arch Gen

pathophysiological implications.

92. Chapman F.,
et al.
Association

Psychiatry, 1988.
45
:
Brain Res Brain Res Rev, 1997.

among visual hallucinations,

814–21.

23
:359–72.

visual acuity, and specific eye

72. DiGirolamo G., Posner M.

82. Gaudreau J., Gagnon P.

pathologies in Alzheimer’s

Attention and schizophrenia: a

Psychogenic drugs and delirium

disease: treatment implications.

view from cognitive neuroscience.

pathogenesis: the central role of

Am J Psychiatry, 1999.

Cogn Neuropsychiatry, 1996.

the thalamus. Med Hypotheses,

156
:1983–5.

1
:95–102.

2005.
64
:471–5.

93. Barnes J., David A. Visual

73. Chen Y.,
et al.
Motion perception
83. Braun C.,
et al.
Brain modules of
hallucinations in Parkinson’s

in schizophrenia. Arch Gen

hallucination: an analysis of

disease: a review and

Psychiatry, 1999.
56
:
multiple patients with brain

phenomenological survey.

149–54.

lesions. J Psych Neurosci, 2003.

J Neurol Neurosurg Psychiatry,

74. Gabrovska V.,
et al.
Evidence for
28
:432–9.

2001.
70
:727–33.

an associative visual agnosia in

84. Teunisse R.,
et al.
Visual

94. Mosimann M.,
et al.
Visual

schizophrenia. Schizophr Res,

hallucinations in psychologically

perception in Parkinson disease

2002.
59
:277–86.

normal people: Charles Bonnet’s

dementia and dementia with

75. Slaghuis W., Bakker V. Forward

Syndrome. Lancet, 1996.

Lewy bodies. Neurology, 2004.

and backward visual masking of

347
:794–7.

63
:2091–6.

contour by light in positive

85. Bonnet C. (1769). Essai

95. Bohnen N.,
et al.
Cortical

symptom and negative symptom

Analytique Sur les Facultés de

cholinergic function is more

schizophrenia. J Abnorm Psychol,

L’âme. 2nd ed., Copenhague:

severely affected in Parkinsonian

1995.
104
:41–54.

Philbert.

dementia than in Alzheimer

76. Selemon L., Rajkowska G.,

86. Holroyd S., Shepherd M., Downs

disease: an in vivo positron

Goldman-Rakic P. Abnormally

J. Occipital atrophy is associated

emission tomographic study. Arch

high neuronal density in the

with visual hallucinations in

Neurol Psychiatry, 2003.

schizophrenic cortex: a

Alzheimer’s disease. J

60
:1745–8.

morphometric analysis of

Neuropsychiatry Clin Neurosci,

96. Harding A., Broe G., Halliday G.

prefrontal area 9 and occipital

2000.
12
:25–8.

Visual hallucinations in Lewy

area 17. Arch Gen Psychiatry,

87. Lhermitte M. Syndrome de la

body disease relate to Lewy bodies

1995.
52
:805–18.

calotte due penduncule cerebral.

in the temporal lobe. Brain, 2002.

77. Tadin D.,
et al.
Believing is seeing
Les troubels psycho-sensoriels

125
:391–403.

in schizophrenia: the role of

dans les lesions du mesocephale.

97. Halliday G.,
et al.
Loss of